Renhe Pharmacy Co

Renhe Pharmacy Co Inventory

The Inventory of Renhe Pharmacy Co (000650.SZ) as of Nov 19, 2026 is 531.11 M CNY. In the previous year, Inventory was 486.94 M CNY — a change of 9.07% (higher).

Inventory

531.11 MCNY

YoY

9.07%

Last updated:

Inventory of Renhe Pharmacy Co is 2025 531.11 M CNY. Inventory of Renhe Pharmacy Co was 2024 486.94 M CNY. It decreases by 9.07% higher compared to the previous year.

The Renhe Pharmacy Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
533.05 M CNY
Jan 1, 2019
522.95 M CNY
Jan 1, 2020
465.35 M CNY
Jan 1, 2021
601.35 M CNY
Jan 1, 2022
457.74 M CNY
Jan 1, 2023
446.58 M CNY
Jan 1, 2024
486.94 M CNY
Jan 1, 2025
531.11 M CNY
The Renhe Pharmacy Co Inventory history
YEARInventoryYoY
531.11 MCNY+9.07%
486.94 MCNY+9.04%
446.58 MCNY-2.44%
457.74 MCNY-23.88%
601.35 MCNY+29.23%
465.35 MCNY-11.01%
522.95 MCNY-1.90%
533.05 MCNY+16.92%
455.90 MCNY-0.24%
456.99 MCNY+23.82%
369.09 MCNY+21.65%
303.40 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renhe Pharmacy Co Stock analysis

What does Renhe Pharmacy Co do? Renhe Pharmacy Co., Ltd. generates revenue through the manufacturing and distribution of pharmaceutical products including capsules, granules, tablets, powder, injections, suppositories, and ointment. The company operates in the domestic market, focusing on medical industrial manufacturing and medical merchandising. Its primary customers are domestic healthcare providers and retail outlets purchasing health-related products for distribution or direct consumer use. The firm's product portfolio spans various dosage forms essential for medical treatment and patient care. The company's business model relies on both wholesale and retail channels within China, serving the domestic pharmaceutical market. Renhe Pharmacy's manufacturing segment produces a wide range of medication forms, while its merchandising division handles the sale of health-related products. This dual approach allows the company to capture value across the pharmaceutical supply chain from production to consumer. Renhe Pharmacy Co., Ltd. serves the Chinese domestic market exclusively, with its operations centered on medical industrial manufacturing and medical merchandising. The company's revenue streams are derived from the sale of its diverse product range to healthcare institutions, pharmacies, and consumers through its retail network. This integrated approach ensures consistent market presence and customer reach within its geographic focus. Renhe Pharmacy Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renhe Pharmacy Co stock

Inventory of Renhe Pharmacy Co is 531.11 M CNY in 2025.

Inventory of Renhe Pharmacy Co changed from 486.94 M CNY to 531.11 M CNY, representing a 9.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Renhe Pharmacy Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Renhe Pharmacy Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Renhe Pharmacy Co

All Key Metrics — Renhe Pharmacy Co